Your Cart ( 1 Item )

• Cost Per Additional Responder Associated With Ixekizumab and Etanercept in the Treatment of Moderate-to-Severe Psoriasis
  December 2017 | Volume 16 | Issue 12 | Original Article | 1246 | Copyright © December 2017
  Steven R. Feldman MD PhD,^a Shonda A. Foster PharmD MS,^b Baojin Zhu PhD,b Russel Burge PhD,^b,c Sarah Al Sawah PhD,^b and Orin M. Goldblum MD^b
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs